tirzepatide surmount SURMOUNT-5: Bests Semaglutide in Head-to-Head Weight Loss Trial Shifts in body mass index

The FDA approval process exists specifically to ensure these standards

These results represent a significant advancement over earlier GLP-1 receptor agonists and positioned tirzepatide as the clinical gold standard for pharmacological weight management heading into the mid-2020s

30 60

Whether you are on your first dose or months into your protocol, understanding these dietary landmines will make the difference between suffering through side effects and sailing through your weight loss journey with minimal disruption

Consult your healthcare provider to discuss possible adjustments, such as modifying the dosage, evaluating your diet and lifestyle factors, or considering alternative treatment options